PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.\', \'The University of Pittsburgh and Carnegie Mellon University Program for Computational Biology, Pittsburgh, PA, USA.\', \'Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Medical Scientist Training Program, University of Pittsburgh School of Medicine and Carnegie Mellon University, Pittsburgh, PA, USA.\', \'School of Computer Science and Engineering, Institute of Life Sciences, The Hebrew University of 6, Jerusalem, Israel.\', \'Department of Structural Biology, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Department of Structure Biology, St. Jude Children\'s Research Hospital, Memphis, TN, USA.\', \'Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA.\', \'Department of Biochemistry, Case Western Reserve University, Cleveland, OH, USA.\', \'School of Computer Science and Engineering, Institute of Life Sciences, The Hebrew University of 6, Jerusalem, Israel. dina.schneidman@mail.huji.ac.il.\', \'Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA. chengzh@pitt.edu.\', \'Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. wxh180@case.edu.\', \'The University of Pittsburgh and Carnegie Mellon University Program for Computational Biology, Pittsburgh, PA, USA. yi.shi@pitt.edu.\', \'Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA. yi.shi@pitt.edu.\', \'Medical Scientist Training Program, University of Pittsburgh School of Medicine and Carnegie Mellon University, Pittsburgh, PA, USA. yi.shi@pitt.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-24963-3
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34344900
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all